Nat Biotechnol 2003,21(6):639–644 PubMedCrossRef 14 Shlomai A, S

Nat Biotechnol 2003,21(6):639–644.PubMedCrossRef 14. Shlomai A, Shaul Y: Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003,37(4):764–770.PubMedCrossRef 15. Ying RS, Zhu C, Fan XG, Li N, Tian XF, Liu HB, Zhang BX: Hepatitis B virus is inhibited by RNA interference in cell

culture and in mice. Antiviral Res 2007,73(1):24–30.PubMedCrossRef 16. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun HDAC inhibitor review E: Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003,8(5):769–776.PubMedCrossRef 17. Chen Y, Cheng G, Mahato RI: RNAi for treating hepatitis B viral infection. Pharm Res 2008,25(1):72–86.PubMedCrossRef 18. Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot P: Expressed anti-HBV primary microRNA beta-catenin assay Pitavastatin solubility dmso shuttles inhibit viral replication efficiently in vitro

and in vivo. Mol Ther 2008,16(6):1105–1112.PubMedCrossRef 19. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP: Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 2008,14(11):1777–1780.PubMedCrossRef 20. Tran TT, Trinh TN, Abe K: New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008,82(11):5657–5663.PubMedCrossRef 21. Colson P, Roquelaure B, Tamalet C: Detection of a newly identified hepatitis B virus genotype in southeastern France. J Clin Virol 2009,45(2):165–167.PubMedCrossRef

22. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, Acharya SK, Gish RG, Kramvis A, Shimada T, Izumi N, et al.: Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006,44(4):915–924.PubMedCrossRef 23. Wu HL, Huang LR, Huang CC, Lai HL, Liu CJ, Huang YT, Hsu YW, Lu CY, Chen DS, Chen PJ: RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 2005,128(3):708–716.PubMedCrossRef 24. Medina MF, Joshi S: RNA-polymerase III-driven expression cassettes in human gene therapy. Curr Opin Mol Ther 1999,1(5):580–594.PubMed 25. Interleukin-2 receptor Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA: Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006,441(7092):537–541.PubMedCrossRef 26. Keck K, Volper EM, Spengler RM, Long DD, Chan CY, Ding Y, McCaffrey AP: Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency. Mol Ther 2009,17(3):538–547.PubMedCrossRef 27. Bredehorst R, von Wulffen H, Granato C: Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen. J Clin Microbiol 1985,21(4):593–598.PubMed 28.

Comments are closed.